CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 loaded by vectors could induce high rates of specific site genome editing and correct disease-causing mutations. However, most monogenic genetic diseases such as hemophilia are caused by different mutations dispersed in one gene...
Main Authors: | Qingnan Wang, Xiaomei Zhong, Qian Li, Jing Su, Yi Liu, Li Mo, Hongxin Deng, Yang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120301492 |
Similar Items
-
In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system
by: Qian Li, et al.
Published: (2021-03-01) -
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
by: Matthew Behr, et al.
Published: (2021-08-01) -
Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology
by: Yanchun Ma, et al.
Published: (2022-07-01) -
CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells
by: Xianglian Ge, et al.
Published: (2016-01-01) -
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
by: Daniel Stone, et al.
Published: (2021-03-01)